Serum concentration of Hakata antigen, a member of the ficolins, is linked with inhibition of Aerococcus viridans growth

Clinica Chimica Acta

Volumn 325, Issue 1-2, 2002, Pages 139-146

  Tsujimura, Mitsushi ^a   Miyazaki, Takashi ^a   Kojima, Eijiro ^a   Sagara, Yasuko ^a   Shiraki, Hiroshi ^a   Okochi, Kazuo ^a   Maeda, Yoshiaki ^a  

^a Japanese Red Cross Kyushu Block Blood Center   (Japan)

Author keywords

Autoimmune diseases; Complement; Hakata antigen; Innate immunity; Serum lectin

Indexed keywords

ACID CITRATE DEXTROSE; ALLOANTIGEN; HAKATA ANTIGEN; MANNOSE BINDING PROTEIN; POLYSACCHARIDE; PROTEIN SUBUNIT; SERINE PROTEINASE; UNCLASSIFIED DRUG;

AEROCOCCUS VIRIDANS; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; BACTERIAL GROWTH; BACTERIUM; COMPLEX FORMATION; CONCENTRATION RESPONSE; ESCHERICHIA COLI; GROWTH INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; STAPHYLOCOCCUS AUREUS; YERSINIA ENTEROCOLITICA;

CARRIER PROTEINS; COMPLEMENT ACTIVATION; COMPLEMENT C4; GLYCOPROTEINS; HUMANS; IMMUNITY; LECTINS; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; POLYSACCHARIDES, BACTERIAL; PROTEIN BINDING; SERINE ENDOPEPTIDASES; STREPTOCOCCACEAE;

AEROCOCCUS; AEROCOCCUS VIRIDANS; ESCHERICHIA COLI; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; YERSINIA; YERSINIA ENTEROCOLITICA;

EID: 0036844208     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00274-7     Document Type: Article

References (22)

1. Epstain W.V., Tan M. An antibody-like material in systemic lupus erythematosus directed toward a thermolabile serum macroprotein. Arthritis Rheum. 16:1973;43-51.
2. Inaba S., Okochi K. On a new precipitating antibody against normal human serum found in two patients with SLE. Igaku No Ayumi. 107:1978;690-691. [In Japanese].
3. Inaba S., Okochi K., Yae Y., Niklasson F., De-Verdier C.H. Serological studies of an SLE-associated antigen-antibody system discovered as a precipitation reaction in agarose gel: the Hakata antigen-antibody system. Fukuoka Acta Med. 81:1990;284-291.
4. Yae Y., Inaba S., Sato H., Okochi K., Tokunaga F., Iwanaga S. Isolation and characterization of a thermolabile β-2 macroglycoprotein (thermolabile substance or Hakata antigen) detected by precipitating (auto) antibody in sera of patients with systemic lupus erythematosus. Biochim. Biophys. Acta. 1078:1991;369-376.
5. Yoshizawa S., Nagasawa K., Yae Y., Niho Y., Okochi K. A thermolabile β-2 macroglycoprotein (TMG) and the antibody against TMG in patients with systemic lupus erythematosus. Clin. Chim. Acta. 264:1997;219-225.
6. Fukutomi T., Ando B., Sakamoto S., Sakai H., Nawata H. Thermolabile β-2 macroglycoprotein (Hakata antigen) in liver disease: biochemical and immunohistochemical study. Clin. Chim. Acta. 255:1996;93-106.
7. Sugimoto R., Yae Y., Akaiwa M.et al. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J. Biol. Chem. 273:1998;20721-20727.
8. Tsujimura M., Ishida C., Sagara Y.et al. Serum thermolabile β-2-macroglycoprotein (HAKATA antigen) binding activity of polysaccharide produced by Aerococcus Viridans. Clin. Diagn. Lab. Immunol. 8:2001;454-459.
9. Matsushita M., Endo Y., Fujita T. Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J. Immunol. 164:2000;2281-2284.
10. Matsushita M., Endo Y., Taira S.et al. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as a opsonin. J. Biol. Chem. 271:1996;2448-2454.
11. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1992;1497-1502.
12. Thiel S., Vorup-Jensen T., Stover C.M.et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 386:1997;506-510.
13. Dahl M.R., Thiel S., Matsushita M.et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 15:2001;127-135.
14. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., Fujita T. Activation of the lectin complement pathway by H-ficolin. J. Immunol. 168:2002;3502-3506.
15. Terai I., Kobayashi K., Matsushita M., Fujita T. Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of concentrations in body fluids and identification of two forms in serum. Clin. Exp. Immunol. 110:1997;317-323.
16. Kuhlman M., Joiner K., Ezekowitz A. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169:1989;1733-1745.
17. Schweinie J.E., Ezaekowitz R.A.B., Tenner A.J., Kuhlman M., Joiner K.A. Human mannose-binding protein activites the alternative complement pathway and enhances serum bacteriocidal activity on a mannose-rich isolate of Salmonella. J. Clin. Invest. 84:1989;1821-1829.
18. Madsen H.O., Garred P., Kurthals J.A.et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics. 40:1994;37-44.
19. Thiel S., Petersen S.V., Vorup-Jensen T.et al. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19. J. Immunol. 165:2000;878-887.
20. Super M., Thiel S., Lu J., Levinsky R.J., Turner M.W. Association of low concentrations of mannan-binding protein with a common defect of opsonisation. Lancet. ii:1989;1236-1239.
21. Neth O., Hann I., Turner M.W., Klein N.J. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet. 358:2001;614-618.
22. Perterslund N.A., Koch C., Jensenius J.C., Thiel S. Association between deficiency of mannose-binding lectin and severe infection after chemotherapy. Lancet. 358:2001;637-638.